Get startedLog in
    Picture of Pilulka Lekarny as logo

    PINK — Pilulka Lekarny as Income Statement

    0.000.00%
    cz flag iconLast trade - 00:00
    Consumer DefensivesHighly SpeculativeMicro Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Pilulka Lekarny as, fiscal year end - December 31st, CZK millions except per share, conversion factor applied.

    R2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    CAS
    CAS
    CAS
    CAS
    CAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue1,2391,7802,3802,4472,132
    Cost of Revenue
    Gross Profit127198238260166
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses1,2841,7792,3942,4952,280
    Operating Profit-44.81.06-14-47.7-148
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-52.1-25.1-24.7-64-176
    Provision for Income Taxes
    Net Income After Taxes-50.7-25.6-25.7-65.8-176
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income-45.5-21.9-25.5-64.9-175
    Adjustments to Net Income
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-45.5-21.9-25.5-64.9-175
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-21.5-7.81-5.34-24.8-63.7
    Dividends per Share